REGISTERED
on 17 Oct 2023
Last Applicant/ Owned by
One Tower Center Blvd.
East Brunswick
NJ
08816
Serial Number
90980395 filed on 08th Jul 2021
Registration Number
7197022 registered on 17th Oct 2023
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
AVETAPI
Full line of neurological, central nervous system, anti-inflammatory, cardiovascular, renal, anti-microbial, anti-neoplastic, immunomodulatory, hematopoietic, anticoagulant, thrombolytic, antiplatelet, estrogenic, progestin, androgen, thyroid, anti-thyroid, ophthalmic, histamine H2 receptor antagonist, proton pump antagonist, anti-emetic, anti-convulsant, anti-asthmatic and anti-diabetic pharmaceu Read More
Classification Information
Class [005]
Pharmaceutical Products
Full line of neurological, central nervous system, anti-inflammatory, cardiovascular, renal, anti-microbial, anti-neoplastic, immunomodulatory, hematopoietic, anticoagulant, thrombolytic, antiplatelet, estrogenic, progestin, androgen, thyroid, anti-thyroid, ophthalmic, histamine H2 receptor antagonist, proton pump antagonist, anti-emetic, anti-convulsant, anti-asthmatic and anti-diabetic pharmaceutical preparations
First Use Date in General
04th Aug 2023
First Use Date in Commerce
04th Aug 2023
Mark Details
Serial Number
No 90980395
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 134393-01100
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 17th Oct 2023 | REGISTERED-PRINCIPAL REGISTER |
| 17th Oct 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 14th Sep 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 13th Sep 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 12th Sep 2023 | DIVISIONAL PROCESSING COMPLETE |
| 12th Sep 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 28th Aug 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 08th Aug 2023 | TEAS STATEMENT OF USE RECEIVED |
| 08th Aug 2023 | TEAS REQUEST TO DIVIDE RECEIVED |
| 08th Aug 2023 | DIVISIONAL REQUEST RECEIVED |